Your browser doesn't support javascript.
loading
Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein more reliably distinguishes liver fibrosis stages in non-alcoholic fatty liver disease than serum Mac-2 binding protein.
Atsukawa, Masanori; Tsubota, Akihito; Okubo, Tomomi; Arai, Taeang; Nakagawa, Ai; Itokawa, Norio; Kondo, Chisa; Kato, Keizo; Hatori, Tsutomu; Hano, Hiroshi; Oikawa, Tsunekazu; Emoto, Naoya; Abe, Masanori; Kage, Masayoshi; Iwakiri, Katsuhiko.
Afiliación
  • Atsukawa M; Department of Internal Medicine, Division of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan.
  • Tsubota A; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.
  • Okubo T; Core Research Facilities for Basic Science, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan.
  • Arai T; Department of Internal Medicine, Division of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan.
  • Nakagawa A; Department of Internal Medicine, Division of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan.
  • Itokawa N; Department of Internal Medicine, Division of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan.
  • Kondo C; Department of Internal Medicine, Division of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan.
  • Kato K; Department of Internal Medicine, Division of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan.
  • Hatori T; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Shinmatsudo Central General Hospital, Chiba, Japan.
  • Hano H; Department of Pathology, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan.
  • Oikawa T; Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan.
  • Emoto N; Department of Gastroenterology and Hepatology, The Jikei University School of Medicine, Tokyo, Japan.
  • Abe M; Department of Internal Medicine, Division of Endocrinology, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan.
  • Kage M; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Ehime, Japan.
  • Iwakiri K; Molecular Targeting Therapeutics Division, Research Center for Innovative Cancer Therapy, Kurume University, Fukuoka, Japan.
Hepatol Res ; 48(6): 424-432, 2018 May.
Article en En | MEDLINE | ID: mdl-29274190
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Hepatol Res Año: 2018 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Hepatol Res Año: 2018 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos